Skip to main content
Erschienen in: Osteoporosis International 12/2010

01.12.2010 | Original Article

Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly

verfasst von: M. Madeira, L. V. Neto, G. A. B. de Lima, R. O. Moreira, L. M. C. de Mendonça, M. R. Gadelha, M. L. F. Farias

Erschienen in: Osteoporosis International | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Summary

Studies on body composition and bone mineral density in acromegaly have conflicting results. Our data point to an increase in lean mass, a decrease in adipose tissue, and that the anabolic effect of GH on bone is partially dependent on modifications in body composition.

Introduction

The effects of growth hormone (GH) and insulin-like growth factor I (IGF-I) excess and gonadal status on bone mineral density (BMD) and body composition (BC) in acromegalic patients are uncertain.

Methods

Bone mineral density and BC were evaluated by dual-energy X-ray absorptiometry (Prodigy-GE) in 75 patients (22 men and 53 women) with acromegaly, mean age 48.9 ± 14.5 years. Acromegaly was considered “controlled” when serum IGF-I was within the specific age-adjusted reference range, and serum GH was lower than 2.5 ng/mL. Comparisons between groups were performed using unpaired t test or Mann–Whitney U test. Categorical variables were analyzed by chi-square (x 2) test. In order to compare data of different subgroups stratified by disease activity and gonadal status, one-way analysis of variance (ANOVA) and Bonferroni post hoc analysis were performed. To evaluate the correlation between GH and IGF-I and densitometric parameters, Pearson and Spearman rank order correlation were performed, as appropriate.

Results

There were no differences in BMD when considering disease activity and gonadal status. Active disease and eugonadism were positively correlated to an increase in lean mass and a decrease in fat mass. After multiple linear regression, there were positive correlations between GH and Z-score at lumbar spine and between lean mass and BMD at proximal femur.

Conclusion

Our data support that GH-IGF-I excess and eugonadism have great influence on BC modifications and that the anabolic effects of GH-IGF-I on bone are, at least in part, dependent on these alterations in body composition.
Literatur
1.
Zurück zum Zitat Stracke H, Schulz A, Moeller D, Rossol S, Schatz H (1984) Effect of growth hormone on osteoblasts and demonstration of somatomedin C/IGF-I in bone organ culture. Acta Endocrinol 107:16–24PubMed Stracke H, Schulz A, Moeller D, Rossol S, Schatz H (1984) Effect of growth hormone on osteoblasts and demonstration of somatomedin C/IGF-I in bone organ culture. Acta Endocrinol 107:16–24PubMed
2.
Zurück zum Zitat Canalis E, McCarthy TL, Centrella M (1989) The role of growth factors in skeletal remodelling. Endocrinol Metab Clin North Am 18:903–918PubMed Canalis E, McCarthy TL, Centrella M (1989) The role of growth factors in skeletal remodelling. Endocrinol Metab Clin North Am 18:903–918PubMed
3.
Zurück zum Zitat Ezzat S, Melmed S, Endres D, Exre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452–1457CrossRefPubMed Ezzat S, Melmed S, Endres D, Exre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452–1457CrossRefPubMed
4.
Zurück zum Zitat Halloran BP, Spencer EM (1988) Dietary phosphorus and 1, 25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinology 123:1225–1229CrossRefPubMed Halloran BP, Spencer EM (1988) Dietary phosphorus and 1, 25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinology 123:1225–1229CrossRefPubMed
5.
Zurück zum Zitat Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535–559CrossRefPubMed Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535–559CrossRefPubMed
6.
Zurück zum Zitat Gavin J, Gorden P, Roth J, Archer A, Buell DN (1973) Characteristics of the human lymphocyte insulin receptor. J Biol Chem 248:2202–2207PubMed Gavin J, Gorden P, Roth J, Archer A, Buell DN (1973) Characteristics of the human lymphocyte insulin receptor. J Biol Chem 248:2202–2207PubMed
7.
Zurück zum Zitat Goodman HM, Kostyo JL (1981) Altered profiles of biological activity of growth hormone fragments on adipocyte metabolism. Endocrinology 108:553–558CrossRefPubMed Goodman HM, Kostyo JL (1981) Altered profiles of biological activity of growth hormone fragments on adipocyte metabolism. Endocrinology 108:553–558CrossRefPubMed
8.
Zurück zum Zitat Goodman HM (1965) In vitro actions of growth hormone on glucose metabolism in adipose tissue. Endocrinology 76:216–225CrossRefPubMed Goodman HM (1965) In vitro actions of growth hormone on glucose metabolism in adipose tissue. Endocrinology 76:216–225CrossRefPubMed
9.
Zurück zum Zitat Pascual M, Larralde J, Martinez JA (1995) Insulin-like growth factor I (IGF-I) affects plasma lipid profile and inhibits the lipolytic action of growth hormone (GH) in isolated adipocytes. Life Sci 57:1213–1218CrossRefPubMed Pascual M, Larralde J, Martinez JA (1995) Insulin-like growth factor I (IGF-I) affects plasma lipid profile and inhibits the lipolytic action of growth hormone (GH) in isolated adipocytes. Life Sci 57:1213–1218CrossRefPubMed
10.
11.
Zurück zum Zitat Kaji H, Sugimoto T, Nakaoka D, Okimura Y, Kaji H, Abe H, Chihara K (2001) Bone metabolism and body composition in japanese patients with active acromegaly. Clin Endocrinol 55:175–181CrossRef Kaji H, Sugimoto T, Nakaoka D, Okimura Y, Kaji H, Abe H, Chihara K (2001) Bone metabolism and body composition in japanese patients with active acromegaly. Clin Endocrinol 55:175–181CrossRef
12.
Zurück zum Zitat Sucunza N, Barahona MJ, Resmini E, Fernandez-Real JM, Farrerons J, Lluch P, Puig T, Wagner AM, Ricart W, Webb SM (2008) Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females. Eur J Endocrinol 159:773–779CrossRefPubMed Sucunza N, Barahona MJ, Resmini E, Fernandez-Real JM, Farrerons J, Lluch P, Puig T, Wagner AM, Ricart W, Webb SM (2008) Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females. Eur J Endocrinol 159:773–779CrossRefPubMed
13.
Zurück zum Zitat O’Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KK (1994) Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 78:381–386CrossRefPubMed O’Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KK (1994) Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 78:381–386CrossRefPubMed
14.
Zurück zum Zitat Diamond T, Nery L, Posen S (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111:567–573PubMed Diamond T, Nery L, Posen S (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111:567–573PubMed
15.
Zurück zum Zitat Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A, Bollerslev J (2002) Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest 32:122–128CrossRefPubMed Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A, Bollerslev J (2002) Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest 32:122–128CrossRefPubMed
16.
Zurück zum Zitat Bolanowski M, Daroszewski J, Medras M, Zadrozna-Sliwka B (2006) Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 24:72–78CrossRefPubMed Bolanowski M, Daroszewski J, Medras M, Zadrozna-Sliwka B (2006) Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 24:72–78CrossRefPubMed
17.
Zurück zum Zitat Kayath MJ, Vieira JGH (1997) Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporosis Int 7:226–230CrossRef Kayath MJ, Vieira JGH (1997) Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporosis Int 7:226–230CrossRef
18.
Zurück zum Zitat Lesse GP, Fraser WD, Farquharson R et al (1998) Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf) 48:59–65CrossRef Lesse GP, Fraser WD, Farquharson R et al (1998) Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf) 48:59–65CrossRef
19.
Zurück zum Zitat Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P (2007) In acromegaly, increased bone mineral density is determined by GH excess, gonadal function and gender. Neuro Endocrinol Lett 28:621–628PubMed Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P (2007) In acromegaly, increased bone mineral density is determined by GH excess, gonadal function and gender. Neuro Endocrinol Lett 28:621–628PubMed
20.
Zurück zum Zitat Ho PJ, Fig LM, Barkan AL, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33:1608–1612PubMed Ho PJ, Fig LM, Barkan AL, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33:1608–1612PubMed
21.
Zurück zum Zitat Kotzmann H, Bernecker P, Hubsch P et al (1993) Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 8:459–465CrossRefPubMed Kotzmann H, Bernecker P, Hubsch P et al (1993) Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 8:459–465CrossRefPubMed
22.
Zurück zum Zitat Longobardi S, Di Somma C, Di Rella F, Angelillo N, Ferone D, Colao A, Merola B, Lombardi G (1998) Bone mineral density and circulating cytokines in patients with acromegaly. J Endocrinol Invest 21:688–693PubMed Longobardi S, Di Somma C, Di Rella F, Angelillo N, Ferone D, Colao A, Merola B, Lombardi G (1998) Bone mineral density and circulating cytokines in patients with acromegaly. J Endocrinol Invest 21:688–693PubMed
23.
Zurück zum Zitat Giustina A, Barkan A, Casanueva FF, Cavagnini F, Froman L, Ho K, Veldhuiss J, Wass J, Von Wereder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529CrossRefPubMed Giustina A, Barkan A, Casanueva FF, Cavagnini F, Froman L, Ho K, Veldhuiss J, Wass J, Von Wereder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529CrossRefPubMed
24.
Zurück zum Zitat Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A (2009) Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin Endocrinol 70:378–382CrossRef Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A (2009) Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin Endocrinol 70:378–382CrossRef
25.
Zurück zum Zitat Scillitani A, Battista C, Chiodini I, Carnevale V et al (2003) Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin Endocrinol 58:725–731CrossRef Scillitani A, Battista C, Chiodini I, Carnevale V et al (2003) Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin Endocrinol 58:725–731CrossRef
26.
Zurück zum Zitat Bengtsson BA, Brummer RJ, Eden S, Bosaeus I, Lindstedt G (1989) Body composition in acromegaly: the effect of treatment. Clin Endocrinol 31:481–490CrossRef Bengtsson BA, Brummer RJ, Eden S, Bosaeus I, Lindstedt G (1989) Body composition in acromegaly: the effect of treatment. Clin Endocrinol 31:481–490CrossRef
27.
Zurück zum Zitat Alois JF, Roginski MS, Jowsey J, Dombrowski CS, Shukla KK, Cohn SH (1972) Skeletal metabolism and body composition in acromegaly. J Clin Endocrinol Metab 35:543–551CrossRef Alois JF, Roginski MS, Jowsey J, Dombrowski CS, Shukla KK, Cohn SH (1972) Skeletal metabolism and body composition in acromegaly. J Clin Endocrinol Metab 35:543–551CrossRef
28.
Zurück zum Zitat Bengtsson BA, Brummer RJM, Eden S, Bosaeus I (1989) Body composition in acromegaly. Clin Endocrinol (Oxf) 30:121–130CrossRef Bengtsson BA, Brummer RJM, Eden S, Bosaeus I (1989) Body composition in acromegaly. Clin Endocrinol (Oxf) 30:121–130CrossRef
29.
Zurück zum Zitat Reid IR (2002) Relationships among body mass, its components, and bone. IBMS BoneKEy 55:1–16 Reid IR (2002) Relationships among body mass, its components, and bone. IBMS BoneKEy 55:1–16
Metadaten
Titel
Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly
verfasst von
M. Madeira
L. V. Neto
G. A. B. de Lima
R. O. Moreira
L. M. C. de Mendonça
M. R. Gadelha
M. L. F. Farias
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 12/2010
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-1165-x

Weitere Artikel der Ausgabe 12/2010

Osteoporosis International 12/2010 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.